ANAVEX LIFE SCIENCES CORP. Deferred Income Tax Expense (Benefit)
ANAVEX LIFE SCIENCES CORP. (AVXL) reported Deferred Income Tax Expense (Benefit) of $7.00 thousand for the 12-month period ending 2023-09-30, per its 10-K/A filed 2026-08-28.
Financial Statements › Cash Flow › Operating Activities
us-gaap:DeferredIncomeTaxExpenseBenefit · last filed 2026-08-28
- ANAVEX LIFE SCIENCES CORP. deferred income tax expense (benefit) for fiscal 2023 was $7.00K, a 98.04% decline from fiscal 2022.
- ANAVEX LIFE SCIENCES CORP. deferred income tax expense (benefit) for fiscal 2022 was $358.00K, a 33.58% increase from fiscal 2021.
- ANAVEX LIFE SCIENCES CORP. deferred income tax expense (benefit) for fiscal 2021 was $268.00K, a 1082.49% increase from fiscal 2020.
- ANAVEX LIFE SCIENCES CORP. deferred income tax expense (benefit) for fiscal 2020 was $22.66K, a 72.42% decline from fiscal 2019.
| Period end | Deferred Income Tax Expense (Benefit) 12 month | Deferred Income Tax Expense (Benefit) 12 month as first filed |
|---|---|---|
| 2023-09-30 | $7.00K 10-K/A · filed 2026-08-28 | |
| 2022-09-30 | $358.00K 10-K · filed 2023-11-27 | $358.49K 10-K · filed 2022-11-28 |
| 2021-09-30 | $268.00K 10-K · filed 2023-11-27 | $267.56K 10-K · filed 2021-11-24 |
| 2020-09-30 | $22.66K 10-K · filed 2022-11-28 | |
| 2019-09-30 | $82.18K 10-K · filed 2020-12-28 | |
| 2018-09-30 | $72.75K 10-K · filed 2019-12-16 | |
| 2014-09-30 | -$1.40M 10-K · filed 2016-12-14 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Protalix BioTherapeutics, Inc. (PLX) | $0.221B | 9.87 | |
| Alector, Inc. (ALEC) | United States | $0.213B | -1.90 |
| Compass Therapeutics, Inc. (CMPX) | United States | $0.204B | -5.35 |
| Protara Therapeutics, Inc. (TARA) | United States | $0.198B | -3.22 |
| Aligos Therapeutics, Inc. (ALGS) | United States | $0.238B | -0.47 |
| Lineage Cell Therapeutics, Inc. (LCTX) | United States | $0.241B | -10.35 |
| Alpha Cognition Inc. (ACOG) | $0.185B | -6.77 | |
| Coherus Oncology, Inc. (CHRS) | United States | $0.182B | -1.63 |
| SUTRO BIOPHARMA, INC. (STRO) | United States | $0.260B | -3.05 |
| PRECISION BIOSCIENCES INC (DTIL) | United States | $0.175B | -3.95 |